Ultragenyx Reports First Quarter 2021 Financial Results and Corporate Update
Go back to Ultragenyx Reports First Quarter 2021 Financial Results and Corporate Update| Mirenco, Inc. (NASDAQ: MREO) | Delayed: 0.32 -0.01 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.33 | 52 Week High | $0.01 | |||
| Open | $0.32 | 52 Week Low | $0.00 | |||
| Day High | $0.34 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $-0.02 | |||
| Volume | 1,566,544 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 28.76 -0.27 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.03 | 52 Week High | $117.12 | |||
| Open | $28.58 | 52 Week Low | $46.52 | |||
| Day High | $29.39 | P/E | N/A | |||
| Day Low | $28.50 | EPS | $-1.97 | |||
| Volume | 2,042,945 | |||||
